Deep Medicine

Deep Medicine

Core business

We practice Deep Medicine

Or how Artificial Intelligence can help tackle neurodegeneration

In conjunction with increasingly advanced computational approaches, a wide spectrum of neurodegenerative disease models, data-driven or knowledge-driven, have been developed. We want to capture biomedical data to detect neurodegenerative diseases (like Alzheimer’s, Parkinson’s disease) 15-20 years before the symptoms show. AI powered diagnostics and therapies to offer a longer health span.

Products & services

We introduce early non-invasive diagnostics of neurodegenerative diseases among adults aged 45 and up by affordable and an AI powered mobile application using digital biomarkers. Deep Medicine adopts a people-centred approach helping to create technical solutions to fulfil the needs of both patients and doctors with one goal in mind, to contribute to a healthier and longer life span. The solutions we develop use real-world data as the backbone of our innovations. As the diagnostic potential of AI is huge, it could be of fundamental importance in assisting doctors in the diagnosis of a vast number of diseases. The current focus of Deep Medicine lies with neurodegenerative diseases, such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD) and Multiple Sclerosis (MS)

Looking for


Research collaboration

Print this page Send by email
Deep Medicine

Creation date




Organisation type


Certifications & qualifications


R&D investments

+ 1 M €

International locations



Deep Medicine S.A.
29, Avenue Monterey
L-2163 Luxembourg
Grand Duchy of Luxembourg


Annemiek Van Hese

Les cookies participent au bon fonctionnement de ce site internet. En utilisant ce dernier, vous acceptez l’utilisation des cookies. En savoir plus